Into the Non-Coding RNA World of Hepatocellular Carcinoma
A special issue of Livers (ISSN 2673-4389).
Deadline for manuscript submissions: 20 March 2026 | Viewed by 13
Special Issue Editors
Interests: standardizing clinical management; hepatocellular carcinoma
Special Issue Information
Dear Colleagues,
Non-coding RNAs (ncRNAs), such as microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs), have emerged as critical regulators in hepatocellular carcinoma (HCC) pathogenesis and as promising therapeutic targets. This Special Issue will provide a comprehensive update on the latest findings regarding ncRNAs, with a focus on their clinical applications as biomarkers for diagnosis and prognosis, treatment prediction, and ncRNA-based therapeutic strategies from basic mechanisms to delivery system strategies to clinical trials.
We welcome both original research papers and review articles that describe advances in deciphering the etiological and therapeutic links between ncRNAs and HCC, detection methodologies and bioinformatics approaches to uncover ncRNA signatures, fundamental biology and molecular approaches to determine the mechanistic details of ncRNA contributions to HCC, and diagnostic and therapeutic developments that apply this knowledge for HCC treatment.
Dr. Takeshi Suda
Dr. Nobuo Waguri
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Livers is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- hepatocellular carcinoma
- non-coding RNA
- biomarker
- delivery
- clinical trial
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
